16 December 2014
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Change of Adviser
Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces the appointment, with immediate effect, of Panmure Gordon (UK) Limited as its Nominated Adviser and Broker.
-Ends-
For further information
|
Allergy Therapeutics |
+44 (0) 1903 845 820 |
|
Manuel Llobet, Chief Executive Officer |
|
|
Ian Postlethwaite Finance Director |
|
|
Panmure Gordon |
+44 (0) 20 7886 2500 |
|
Freddy Crossley / Duncan Monteith, Corporate Finance |
|
|
Tom Salvesen, Corporate Broking |
|
|
FTI Consulting |
+44 (0) 20 3727 1000 |
|
Simon Conway |
|
|
Victoria Foster Mitchell |
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. Ithas a growing business achieving revenue in thelast financial yearof £42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into theEmerging markets.
This information is provided by RNS